3-Year-Old First to Receive Gene Therapy for Hunter Syndrome

Is this a revolutionary breakthrough that transforms devastating diseases, or experimental treatment with uncertain long-term outcomes?
3-Year-Old First to Receive Gene Therapy for Hunter Syndrome
Above: Laboratory work at a non-profit gene therapy organization in Evry, France on May 10, 2022. Image credit: Eric Piermont/AFP/Getty Images

The Spin

Techno-optimist narrative

Gene therapy is a revolutionary breakthrough that transforms devastating childhood diseases into manageable conditions. Oliver's remarkable recovery proves this cutting-edge treatment can halt progressive neurological decline and restore normal development. The success demonstrates how innovative medical research saves lives when properly funded.

Techno-skeptic narrative

Gene therapy remains experimental with uncertain long-term outcomes despite early promising results. Oliver's case is just one patient in a small trial, and doctors emphasize caution about getting carried away with excitement. The treatment's true effectiveness won't be known until all five boys complete two years of monitoring.

Metaculus Prediction


Articles on this story



© 2025 Improve the News Foundation. All rights reserved.Version 6.18.1

© 2025 Improve the News Foundation.

All rights reserved.

Version 6.18.1